Research Comparison
Cerebrolysin vs Semax
A side-by-side research comparison of Cerebrolysin and Semax drawn from Cobalt Peptides' peptide database records.
Cerebrolysin
Cerebrolysin is a standardised neuropeptide preparation derived from purified porcine brain proteins, containing low-molecular-weight peptides and free amino acids. It is formulated to resemble endogenous neurotrophic factors, and the published literature examines it in the context of neuronal survival and plasticity. Study outcomes across the literature remain mixed. It is of porcine origin. Cerebrolysin is not an approved medicine in the United Kingdom. Supplied strictly as a research compound for laboratory use.
Semax
Semax is a synthetic heptapeptide derived from the ACTH(4-10) fragment, developed in Russia and studied for its effects on the central nervous system. The published literature describes rapid increases in BDNF expression and modulation of dopaminergic and serotonergic signalling. Administered intranasally in study protocols, it is described as reaching the CNS via the olfactory epithelium and trigeminal pathways rather than crossing the blood-brain barrier. Semax is not an approved medicine in the United Kingdom. Supplied strictly as a research compound for laboratory use.